User profiles for "author:Alessandro Giollo"

Alessandro Giollo

Division of Rheumatology, University of Padova
Verified email at unipd.it
Cited by 2055

[HTML][HTML] Drug-induced interstitial lung disease: a systematic review

S Skeoch, N Weatherley, AJ Swift, A Oldroyd… - Journal of clinical …, 2018 - mdpi.com
Background: Drug-induced interstitial lung disease (DIILD) occurs as a result of numerous
agents, but the risk often only becomes apparent after the marketing authorisation of such …

The obesity paradox and osteoporosis

A Fassio, L Idolazzi, M Rossini, D Gatti, G Adami… - Eating and Weight …, 2018 - Springer
Overweight and obesity according to the definition of the WHO are considered as an
abnormal or excessive fat accumulation that may impair health. Studies comparing fracture …

[HTML][HTML] Osteoporosis in rheumatic diseases

G Adami, A Fassio, M Rossini, C Caimmi… - International journal of …, 2019 - mdpi.com
Osteoporosis is a chronic disease characterized by an increased risk of fragility fracture.
Patients affected by rheumatic diseases are at greater risk of developing osteoporosis. The …

Association between environmental air pollution and rheumatoid arthritis flares

G Adami, O Viapiana, M Rossini, G Orsolini… - …, 2021 - academic.oup.com
Objectives Environmental air pollution has been linked to the pathogenesis of RA.
Nevertheless, evidence linking higher concentrations of air pollutants with the risk of RA …

[PDF][PDF] Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID)

A Giollo, G Adami, D Gatti, L Idolazzi… - Annals of the rheumatic …, 2020 - ard.bmj.com
We have read with interest the report by Monti et al 1 concerning the clinical course of
coronavirus disease (Covid-19) in patients with chronic inflammatory arthritis. However, we …

[PDF][PDF] Novel insights into the management of rheumatoid arthritis: one year in review 2022

C Garaffoni, A Adinolfi, A Bortoluzzi… - Clin Exp …, 2022 - clinexprheumatol.org
New evidence for the treatment of rheumatoid arthritis (RA) has emerged during the last
year. Specifically, updated guidelines on pharmacological and non-pharmacological …

One year in review 2020: novelties in the treatment of rheumatoid arthritis

E Silvagni, A Giollo, G Sakellariou, N Ughi… - Clinical and …, 2020 - boa.unimib.it
Rheumatoid arthritis (RA) management is driven by evidence, and new 2019 EULAR
recommendations help in refining the relevant place of different disease-modifying anti …

Primary systemic sclerosis heart involvement: a systematic literature review and preliminary data-driven, consensus-based WSF/HFA definition

C Bruni, MH Buch, DE Furst… - … of Scleroderma and …, 2022 - journals.sagepub.com
Introduction: Primary heart involvement in systemic sclerosis may cause morpho-functional
and electrical cardiac abnormalities and is a common cause of death. The absence of a …

[HTML][HTML] Pharmacokinetics of oral cholecalciferol in healthy subjects with vitamin D deficiency: a randomized open-label study

A Fassio, G Adami, M Rossini, A Giollo, C Caimmi… - Nutrients, 2020 - mdpi.com
Background: The aim of this study was to investigate the pharmacokinetic (PK) and safety
profile of high-dose vitamin D supplementation, comparing different schedules (daily …

Early characterization of difficult-to-treat rheumatoid arthritis by suboptimal initial management: a multicentre cohort study

A Giollo, M Zen, M Larosa, D Astorri, M Salvato… - …, 2023 - academic.oup.com
Objectives To demonstrate that unsuccessful treatment optimization in early disease is
associated with difficult-to-treat RA (D2T-RA). Methods In this retrospective multicentre …